953 related articles for article (PubMed ID: 26328768)
1. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
2. Providing data science support for systems pharmacology and its implications to drug discovery.
Hart T; Xie L
Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
[TBL] [Abstract][Full Text] [Related]
3. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
4. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Ravikumar B; Aittokallio T
Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
[TBL] [Abstract][Full Text] [Related]
5. Better prediction of the local concentration-effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development.
Polak S; Tylutki Z; Holbrook M; Wiśniowska B
Drug Discov Today; 2019 Jul; 24(7):1344-1354. PubMed ID: 31132414
[TBL] [Abstract][Full Text] [Related]
6. Systems Pharmacology in Small Molecular Drug Discovery.
Zhou W; Wang Y; Lu A; Zhang G
Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
[TBL] [Abstract][Full Text] [Related]
7. Systems pharmacology to predict drug toxicity: integration across levels of biological organization.
Bai JP; Abernethy DR
Annu Rev Pharmacol Toxicol; 2013; 53():451-73. PubMed ID: 23140241
[TBL] [Abstract][Full Text] [Related]
8. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
9. Computational approaches for innovative antiepileptic drug discovery.
Talevi A
Expert Opin Drug Discov; 2016 Oct; 11(10):1001-16. PubMed ID: 27454246
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
[TBL] [Abstract][Full Text] [Related]
11. Systems engineering meets quantitative systems pharmacology: from low-level targets to engaging the host defenses.
Androulakis IP
Wiley Interdiscip Rev Syst Biol Med; 2015; 7(3):101-12. PubMed ID: 25778449
[TBL] [Abstract][Full Text] [Related]
12. Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.
Engin HB; Gursoy A; Nussinov R; Keskin O
Curr Pharm Des; 2014; 20(8):1201-7. PubMed ID: 23713773
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
14. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
15. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology - Towards the modeling of network interactions.
Danhof M
Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology beyond reductionism - A likely prospect.
Margineanu DG
Biosystems; 2016 Mar; 141():1-9. PubMed ID: 26723231
[TBL] [Abstract][Full Text] [Related]
18. Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
Vicini P; van der Graaf PH
Clin Pharmacol Ther; 2013 May; 93(5):379-81. PubMed ID: 23598453
[TBL] [Abstract][Full Text] [Related]
19. Structural systems pharmacology: a new frontier in discovering novel drug targets.
Tan H; Ge X; Xie L
Curr Drug Targets; 2013 Aug; 14(9):952-8. PubMed ID: 23597016
[TBL] [Abstract][Full Text] [Related]
20. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
